Second study shows ambulatory BP patterns not tied to cognitive impairment or frailty in CKD patients
The decision to stop the trial was made based on positive efficacy data following a recommendation from the study’s independent DMC.
But high average blood pressure on 24-hour test strongly predicts child’s cardiac, kidney disease risk.
The National Kidney Foundation issued a statement today urging patients on dialysis to continue undergoing treatments during the COVID-19 pandemic. “It is extremely important for kidney patients to continue with their regularly scheduled dialysis treatments and take extra precautions when visiting the facilities to best protect their health,” said Joseph Vassalotti, MD, Chief Medical Officer for NKF. “Skipping…
Glecaprevir/pibrentasvir for 8 to 12 weeks is an effective and well-tolerated treatment for patients with chronic hepatitis C virus and chronic kidney disease stage 4 or 5.
The FDA has granted Fast Track designation for empagliflozin (Jardiance; Boehringer Ingelheim and Lilly) to reduce the risk of kidney disease progression and cardiovascular (CV) death in adults with chronic kidney disease.
The Centers for Disease Control and Prevention has updated the guidance for evaluation of persons under investigation for coronavirus disease 2019 (COVID-19), expanding the criteria to a wider group of symptomatic patients.
Study findings suggest the benefits of continuing ACEi or ARB therapy outweigh the risks in CKD patients with an eGFR less than 30 mL/min/1.73 m2.
People living in areas with higher levels of air pollution may be at higher risk of developing kidney disease.
World Kidney Day 2020 campaign focuses on prevention and detection of chronic kidney disease and equitable access to care.